M&A Deal Summary |
|
|---|---|
| Date | 2021-12-01 |
| Target | Frontida |
| Sector | Life Science |
| Buyer(s) | Adare Pharma Solutions |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2015 |
| Sector | Life Science |
Adare Pharma Solutions provides enhanced medicines, creating new possibilities for improved patient health. Adare Pharma Solutions has solved complex formulation, manufacturing, and commercialization challenges, resulting in transformational medicines that deliver value to all its stakeholders. The company has a global presence with R&D, manufacturing, and commercial operations in the Unites States, Europe, and Canada. Adare Pharma Solutions was founded in 2015 and is based in Lawrenceville, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Pennsylvania M&A | 2 of 2 |
| Country: United States M&A | 3 of 3 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-18 |
Viactiv
Greenwich, Connecticut, United States Viactiv line of supplement chews for bone health, immune health and other applications. Currently marketed through many retailers, including, among others, Walmart (retail and online), Target and Amazon, the Viactiv product lines are expected to become Guardion’s most prominent product lines, as well as to provide access to significant opportunities in the short-term for growth and expansion. Viactiv is based in Greenwich, Connecticut. |
Sell | - |